Professor Michael Berk

Professor Michael Berk is currently appointed to the Chair of Psychiatry for Barwon Health and The Geelong Clinic at The University of Melbourne, is an Honorary Professorial Research fellow at the Mental Health Research Institute, and leads the first episode Bipolar program at Orygen Youth Health. He has published over 200 papers on mood and psychotic disorders, particularly bipolar disorder. He has completed 15 self-initiated randomised controlled trials, predominantly in mood disorders. These include the first two published randomised controlled trials of the atypical antipsychotics and lamotrigine in bipolar disorder, as well as the first positive trials of N-acetyl cysteine in both schizophrenia and Bipolar Disorder. He is the recipient of a number of grants, including Stanley Medical Research Foundation and National Health and Medical Research Council, awards and is Chairman of the International Society of Bipolar Disorders.